Literature DB >> 1784339

An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway.

E E Kaufman1, T Nelson.   

Abstract

Two enzymes have been found which catalyze the initial step in the catabolism of GHB. The oxidation of GHB to SSA, catalyzed by both of these enzymes, is coupled to the reduction of an oxoacid. In the case of the mitochondrial transhydrogenase, the coupling is obligatory. Although coupling is not obligatory for the GHB dehydrogenase, the stimulation provided by the coupled reaction, and the nature of the kinetics of the uncoupled reaction, may not only allow the reaction to proceed, but may provide a means of regulating the rate of the reaction under in vivo conditions. Since the oxidation of GHB to SSA is the rate limiting step in the overall catabolic pathway (the rate of conversion of GHB to SSA proceeds at approximately one one thousandth of the rate at which SSA is oxidized to succinate by SSA dehydrogenase (30)), factors which regulate the rate of either or both of these enzymes will, in turn, influence tissue levels of endogenous GHB as well as the duration and magnitude of the physiological effect of a dose of GHB.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784339     DOI: 10.1007/bf00965839

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  Effects of the anticonvulsant sodium valproate on gamma-aminobutyrate and aldehyde metabolism in ox brain.

Authors:  S R Whittle; A J Turner
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

2.  Content and release of amino-acids and catecholamines in monkey brain.

Authors:  F V DeFeudis; J M Delgado; R H Roth
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

3.  Gammahydroxybutyric acid.

Authors:  M D Vickers
Journal:  Int Anesthesiol Clin       Date:  1969

4.  myo-Inositol oxygenase from hog kidney. I. Purification and characterization of the oxygenase and of an enzyme complex containing the oxygenase and D-glucuronate reductase.

Authors:  C C Reddy; J S Swan; G A Hamilton
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

5.  Effects of gamma-butyrolactone on local cerebral glucose utilization in the rat.

Authors:  L I Wolfson; O Sakurada; L Sokoloff
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

6.  Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro.

Authors:  P Vayer; P Mandel; M Maitre
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

7.  Kinetics of coupled gamma-hydroxybutyrate oxidation and D-glucuronate reduction by an NADP+-dependent oxidoreductase.

Authors:  E E Kaufman; T Nelson
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

8.  Effect of low dose gamma-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat.

Authors:  M H Lavyne; R J Hariri; T Tankosic; T Babiak
Journal:  Neurosurgery       Date:  1983-04       Impact factor: 4.654

9.  Oxidation of gamma-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent enzyme.

Authors:  E E Kaufman; T Nelson; D Miller; N Stadlan
Journal:  J Neurochem       Date:  1988-10       Impact factor: 5.372

10.  Succinic semialdehyde dehydrogenase deficiency: an inborn error of gamma-aminobutyric acid metabolism.

Authors:  K M Gibson; L Sweetman; W L Nyhan; C Jakobs; D Rating; H Siemes; F Hanefeld
Journal:  Clin Chim Acta       Date:  1983-09-15       Impact factor: 3.786

View more
  17 in total

1.  Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid.

Authors:  A R Silva; C Ruschel; C Helegda; A M Brusque; C M Wannmacher; M Wajner; C S Dustra-Filho
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

2.  Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate.

Authors:  Stephanie R Harris; Guo-Fang Zhang; Sushabhan Sadhukhan; Anne M Murphy; Kristyen A Tomcik; Edwin J Vazquez; Vernon E Anderson; Gregory P Tochtrop; Henri Brunengraber
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 3.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.

Authors:  Nisha Vijay; Bridget L Morse; Marilyn E Morris
Journal:  Pharm Res       Date:  2014-12-06       Impact factor: 4.200

5.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

6.  Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.

Authors:  Matthias E Liechti; Boris B Quednow; Evangelia Liakoni; Dario Dornbierer; Robin von Rotz; Maria Salomé Gachet; Jürg Gertsch; Erich Seifritz; Oliver G Bosch
Journal:  Br J Clin Pharmacol       Date:  2016-02-25       Impact factor: 4.335

7.  Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.

Authors:  I Knerr; P L Pearl; T Bottiglieri; O Carter Snead; C Jakobs; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

8.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

9.  Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs.

Authors:  Guo-Fang Zhang; Rajan S Kombu; Takhar Kasumov; Yong Han; Sushabhan Sadhukhan; Jianye Zhang; Lawrence M Sayre; Dale Ray; K Michael Gibson; Vernon A Anderson; Gregory P Tochtrop; Henri Brunengraber
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

10.  Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.

Authors:  Bridget L Morse; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2013-02-07       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.